Growing Demand For Personalized Medicine Shaping The Market Growth Due To People Preferring Health Technologies Is Supporting Development Across The Tumor Models Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

By 2030, How Much Growth In Market Size Is Expected For The Tumor Models Market?

The tumor models market has seen significant expansion recently. It will grow from $2.13 billion in 2025 to $2.37 billion in 2026 at a compound annual growth rate (CAGR) of 11.3%. This historical expansion can be linked to factors such as the restricted access to sophisticated tumor models, a dependence on conventional 2D cell cultures, a rise in funding for cancer research, the increasing incidence of cancer, and the implementation of orthotopic and heterotopic models.

The tumor models market is anticipated to experience substantial expansion over the next few years. It is projected to reach **$3.57 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%**. This growth during the forecast period is primarily driven by advancements in organ-on-a-chip and 3D spheroid technologies, a heightened focus on personalized oncology treatments, the expansion of contract research organizations (CROs) in tumor research, increasing pharmaceutical R&D expenditure, and the integration of AI and big data analytics in tumor model studies. Prominent trends expected in this period include the increasing use of 3D tumor spheroids and organ-on-a-chip models, a rising demand for personalized medicine and targeted cancer therapies, the expansion of xenograft and genetically engineered mouse models (GEMMs), growth in drug discovery and toxicology studies utilizing tumor models, and strengthened collaboration between pharmaceutical companies and academic institutions.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27441&type=smp

Which Major Factors Are Contributing To The Development Of The Tumor Models Market?

The increasing need for personalized medicine is anticipated to drive expansion within the tumor models market. This medical approach involves utilizing genetic and lifestyle data to customize healthcare and treatments for individual requirements. Its increasing prevalence stems from individuals favoring health technologies that provide real-time monitoring and treatment regimens tailored to their distinct biological profiles. Tumor models support personalized medicine by serving as experimental platforms that replicate human cancer behavior, enabling researchers and clinicians to forecast how individual patient tumors will react to specific therapies, thus facilitating a more customized therapeutic strategy. For example, data from February 2024 by the U.S.-based nonprofit, Personalized Medicine Coalition (PMC), indicates that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a notable rise from the 12 approved in 2022. Consequently, the escalating demand for personalized medicine is fueling the expansion of the tumor models market.

How Is The Tumor Models Market Distributed Across Key Segments?

The tumor models market covered in this report is segmented –

1) By Type Of Tumor: Primary Tumor Models, Metastatic Tumor Models, Orthotopic Tumor Models, Heterotopic Tumor Models

2) By Application: Drug Discovery And Development, Cancer Research, Personalized Medicine, Toxicology Studies

3) By Technology: Xenograft Models, Genetically Engineered Mouse Models (GEMMs), Three-Dimensional (3D) Tumor Spheroids, Organ-On-A-Chip Models

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic Institutions, Contract Research Organizations (CROs), Government Research Organizations

Subsegments:

1) By Primary Tumor Models: Carcinoma Models, Sarcoma Models, Glioma Models, Melanoma Models, Leukemia Models, Lymphoma Models

2) By Metastatic Tumor Models: Lung Metastasis Models, Bone Metastasis Models, Liver Metastasis Models, Brain Metastasis Models, Lymph Node Metastasis Models

3) By Orthotopic Tumor Models: Orthotopic Breast Cancer Models, Orthotopic Lung Cancer Models, Orthotopic Pancreatic Cancer Models, Orthotopic Colon Cancer Models, Orthotopic Prostate Cancer Models

4) By Heterotopic Tumor Models: Subcutaneous Tumor Models, Intramuscular Tumor Models, Intraperitoneal Tumor Models

Which Trends Are Shaping The Tumor Models Market Landscape?

Leading companies in the tumor models market are concentrating on creating sophisticated solutions, particularly tumor spheroid models, to improve the physiological relevance and predictive precision of in vitro cancer models. Tumor spheroid models are characterized as three-dimensional (3D) clusters of cancer cells that naturally organize into spherical structures within a culture environment. For example, in June 2024, Predictive Oncology, a US-based company providing advanced 3D cell culture technologies and predictive oncology solutions, introduced new 3D cell technology designed to accelerate the discovery of cancer therapeutic drugs. This technology features several unique aspects, including advanced 3D tumor spheroid and organoid models that closely simulate the tumor microenvironment, high-throughput screening capabilities for rapid drug assessment, support for patient-derived personalized tumor models, comprehensive analysis of drug penetration within 3D structures, and integration with AI-driven data analytics to boost predictive accuracy and offer deeper insights into therapeutic responses.

Who Are The Major Companies Operating In The Tumor Models Market?

Major companies operating in the tumor models market are WuXi AppTec Co Ltd., Charles River Laboratories International Inc., Pharmaron Beijing Co. Ltd., The Jackson Laboratory, Taconic Biosciences Inc., Cyagen Biosciences Inc., Crown Bioscience Inc., Champions Oncology Inc., InSphero AG, Creative Biolabs Inc., Oncodesign S.A., Xentech S.A., MIMETAS BV, Experimental Pharmacology and Oncology Berlin-Buch GmbH.

Access The Complete Tumor Models Market Report:

https://www.thebusinessresearchcompany.com/report/tumor-models-global-market-report

Which Region Contributes The Most To The Tumor Models Market?

North America was the largest region in the tumor models market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor models market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Tumor Models Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=27441&type=smp

Browse Through More Reports Similar to the Global Tumor Models Market 2026, By The Business Research Company

Voice Payment Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/voice-payment-software-global-market-report

Voice Banking Market Report 2026

https://www.thebusinessresearchcompany.com/report/voice-banking-global-market-report

Voice Commerce Market Report 2026

https://www.thebusinessresearchcompany.com/report/voice-commerce-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795